Newswise Feature Channel: Immunology

Nobel Laureate, Prestigious Award Recipients to Speak at American Physiology Summit

American Physiological Society (APS) — Thu, 03 Apr 2025 07:00:32 EST

Nobel Laureate James Rothman, PhD; Holly A. Ingraham, PhD, FASEB's 2024 Lifetime Achievement awardee; and George A. Brooks, PhD, FAPS, the American Physiological Society's (APS) 2025 Walter Cannon Award recipient, are among the highlighted speakers who will attend the American Physiology Summit. The Summit, APS' flagship annual meeting, will be held April 24-27 in Baltimore.

New Study Demonstrates Efficacy and Safety of SEBclausii(tm) (Alkalihalobacillus clausii 088AE) in Treating Acute Allergic Rhinitis

Specialty Enzymes & Probiotics — Thu, 03 Apr 2025 05:55:31 EST

A recently published clinical trial found probiotic SEBclausii(tm) (Alkalihalobacillus clausii 088AE) from Specialty Enzymes & Probiotics supports the alleviation of symptoms of acute allergic rhinitis.

Expert Available: Spring Allergy Season Is In Full Swing

Stony Brook University — Wed, 02 Apr 2025 19:45:46 EST

35-year Industry-Academic Partnership Yielding Groundbreaking Advances for Science and Patients Renews for Another Three Years Between La Jolla Institute for Immunology and Kyowa Kirin

La Jolla Institute for Immunology — Wed, 02 Apr 2025 10:50:00 EST

Together, the two organizations have created a unique alliance that blends the academic prowess of LJI with the drug development and commercialization expertise of Kyowa Kirin.

Brian Brown, PhD, Inducted Into AIMBE College of Fellows for Pioneering Contributions in Gene Therapy and Functional Genomics

Mount Sinai Health System — Mon, 31 Mar 2025 15:00:00 EST

Brian Brown, PhD, Director of the Icahn Genomics Institute at the Icahn School of Medicine at Mount Sinai, has been elected to the College of Fellows of the American Institute for Medical and Biological Engineering (AIMBE).

HealthDay Harris Poll Exclusive Vaccine Attitudes Survey + Interview w/ Dr. Peter Hotez (March 28, 1 PM ET)

HealthDay News — Mon, 31 Mar 2025 13:00:00 EST

A new national survey from HealthDay and The Harris Poll reveals a significant shift in how Americans view vaccines--and what's driving those views.

WHO Releases Update on Measles as Cases Grow

George Washington University — Mon, 31 Mar 2025 09:55:21 EST

Media Briefing: Global State of Malaria: New Research, Evolving Risks, and Silver Linings

Johns Hopkins Bloomberg School of Public Health — Mon, 31 Mar 2025 08:30:10 EST

Make These Scientific Sessions Part of Your Media Coverage

American Thoracic Society (ATS) — Mon, 31 Mar 2025 08:00:00 EST

Register now for a complimentary media pass for ATS 2025 International Conference in San Francisco. We will have breaking news from the leading international conference for pulmonary, critical care and sleep medicine.

Compelling Data Point to a Single, Unknown Respiratory Virus as Cause of Kawasaki Disease

Ann and Robert H. Lurie Children's Hospital of Chicago — Fri, 28 Mar 2025 17:35:52 EST

Cause of Kawasaki disease has been elusive for over 50 years

Immunologist Can Discuss Causes, Treatments for Spring Allergies

Indiana University — Fri, 28 Mar 2025 10:30:03 EST

FAMU-FSU College of Engineering Researchers Create Innovative Microparticles That Unlock New Insights Into Protein Degradation and Immune Cell Behavior

Florida State University — Thu, 27 Mar 2025 19:50:17 EST

FAMU-FSU College of Engineering researchers have created a new method for studying protein degradation within immune cells that uses engineered microparticles to track and analyze degradation processes more effectively than traditional methods. The work, which was published in ACS Applied Materials & Interfaces, has important implications for treating diseases such as cancer, Alzheimer's disease and autoimmune disorders.

Three Wayne State University Professors elected as AAAS Fellows

Wayne State University Division of Research — Thu, 27 Mar 2025 18:40:17 EST

Wayne State University is proud to announce that three professors have been elected as fellows of the American Association for the Advancement of Science (AAAS).

Cuts to Global Vaccine Programs: Johns Hopkins Experts Available

Johns Hopkins Bloomberg School of Public Health — Wed, 26 Mar 2025 21:30:39 EST

Research Finds Potential "Molecular Mimics" Behind COVID-Induced Autoimmune Disease

University of Utah Health — Wed, 26 Mar 2025 21:00:48 EST

COVID infection has been linked to higher risk of autoimmune disorders, including rheumatoid arthritis and type 1 diabetes. Scientists used advanced data analysis and machine learning to identify viral proteins that are more likely to trigger autoimmunity.

UT Southwestern Q&A: What You Need to Know About the Measles

UT Southwestern Medical Center — Wed, 26 Mar 2025 20:15:50 EST

Measles is a highly contagious viral infection that can cause serious health problems. The good news: Two doses of the vaccine developed in the 1960s are 97% effective in protecting you from getting infected, and that protection lasts a lifetime.

Nebraska Undergrads Uncover Ancient Secrets of Human Immunity

University of Nebraska-Lincoln — Wed, 26 Mar 2025 20:10:21 EST

Nebraska undergrads uncover ancient secrets of human immunity

IRCM team identifies crucial mechanism in immune response

Universite de Montreal — Wed, 26 Mar 2025 06:40:15 EST

Nathalie Labrecque and her colleagues have discovered that NOTCH signaling is essential for the differentiation of CD8+ T lymphocytes, optimizing their immune response to infections.

باحثو مايو كلينك يحددون بروتينات مرتبطة بمقاومة العلاج المناعي في سرطان القولون والمستقيم النقيلي

Mayo Clinic — Tue, 25 Mar 2025 21:20:57 EST

قد يساعد اكتشاف جديد أجراه باحثو مايو كلينك في تفسير سبب عدم استجابة العديد من مرضى سرطان القولون والمستقيم النقيلي للعلاج المناعي. ففي نتائج نُشرت في دورية Clinical Cancer Research، حدد الفريق البحثي بروتينات محددة، وهي "الفيبرونيكتين" و"أكتين العضلات الملساء"، داخل أنسجة سرطان القولون والمستقيم، ووجدوا أنها مرتبطة بمقاومة العلاج المناعي.

How Zika Virus Knocks Out Our Immune Defenses

La Jolla Institute for Immunology — Tue, 25 Mar 2025 20:35:34 EST

"Our ultimate goal is to develop vaccines against these very difficult viruses. Understanding how these viruses manipulate the immune response can help guide the development of the best vaccine approach."